Healthcare · Biotech & pharma
Vistin Pharma ASA: Invitation to Q3 2026 conference call
Oslo, Norway, 21 October 2026
Oct 21 · 08:35GlobeNewswire
2,158 press releases in English indexed under biotech & pharma.
Oslo, Norway, 21 October 2026
Boost ROI by outsourcing services, adopting single-use integrated platforms, and standardizing scale-up, optimization and compliance to cut costs and speed production. Boost ROI by outsourcing services, adopting single-use integrated platforms, and standardizing scale-up, optimization and compliance to cut costs and speed production.
Dublin, Oct. 21, 2026 -- "Bioconjugation Market Report 2026" has been added to ResearchAndMarkets.com's offering.
The global clinical trials matching software market was valued at USD 210.7 million in 2025 and is expected to reach USD 237.9 million in 2026. [read full press release...]
Dublin, Oct. 21, 2026 -- "Human Plasma Like Medium Market Report 2026" has been added to ResearchAndMarkets.com's offering.
Dublin, Oct. 21, 2026 -- "Longevity BioTech Market Report 2026" has been added to ResearchAndMarkets.com's offering.
Germany’s ROI opportunities center on synthetic microcarriers, biopharma, vaccines and cell therapies, with automation, single-use systems and sustainable materials improving scale and efficiency. Germany’s ROI opportunities center on synthetic microcarriers, biopharma, vaccines and cell therapies, with automation, single-use systems and sustainable materials improving scale and efficiency.
Dublin, Oct. 21, 2026 -- "White Biotechnology Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.
Cell culture has moved from a basic research technique to the backbone of modern biologics, vaccines, and regenerative medicine. Grand View Research projects the market [read full press release...]
Recorded Q3'26 revenue of KRW 1,490 billion and operating profit of KRW 640 billion Plant 5 ramp-up and U.S. manufacturing operations contribute to earnings performance Raised 2026 revenue growth guidance to 20% while advancing strategic investments in portfolio and capacity expansion...
Also Named Best in Transition (Hong Kong) Recognized for ESG Leadership and Green and Digital Transformation SHANGHAI, Oct. 21, 2026 -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it...
Okomera reaches a key milestone in its industrial rollout with the first commercial installation of its integrated platform, combining hardware, software and biology, in the laboratories of an international pharmaceutical group. Servier will use Okomera's technology to evaluate new therapeutic approaches in oncology and i